Authors:
Mickels, N
McManus, C
Massaro, J
Friden, P
Braman, V
D'Agostino, R
Oppenheim, F
Warbington, M
Dibart, S
Van Dyke, T
Citation: N. Mickels et al., Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis, J CLIN PER, 28(5), 2001, pp. 404-410
Authors:
Lu, XD
Magrane, G
Yin, CY
Louis, DN
Gray, J
Van Dyke, T
Citation: Xd. Lu et al., Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability, MOL CELL B, 21(17), 2001, pp. 6017-6030
Authors:
Pulendran, B
Kumar, P
Cutler, CW
Mohamadzadeh, M
Van Dyke, T
Banchereau, J
Citation: B. Pulendran et al., Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo, J IMMUNOL, 167(9), 2001, pp. 5067-5076
Citation: Ca. Genco et al., Molecular mechanisms of microbial host cell interactions in periodontal disease - Introduction, CLIN INF D, 28(3), 1999, pp. 431-432
Citation: Mj. Liao et T. Van Dyke, Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma, GENE DEV, 13(10), 1999, pp. 1246-1250
Authors:
Liao, MJ
Yin, CY
Barlow, C
Wynshaw-Boris, A
Van Dyke, T
Citation: Mj. Liao et al., Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction, MOL CELL B, 19(4), 1999, pp. 3095-3102
Authors:
de la Coste, A
Mignon, A
Fabre, M
Gilbert, E
Porteu, A
Van Dyke, T
Kahn, A
Perret, C
Citation: A. De La Coste et al., Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice, CANCER RES, 59(19), 1999, pp. 5017-5022